SUMOylation plays a critical role in regulating DAT protein hemostasis, dopamine uptake, and dopamine signaling in neurons; therefore, DAT SUMOylation can be the potential therapeutic target in regulating DAT stability and dopamine clearance in ADHD (Cartier et al., 2019). Here, SLC6A3 is linked to attention deficit-hyperactivity disorder.